Let’s break down the pandemic barriers and regain freedom

29 June 2021 by Joanne Cooper

COVID-19

Consentry by Digi.me is a universal Health Pass application for Government and Industry to remove the burden and challenges of sharing sensitive data by securely managing COVID testing and screening interactions with compliant processes. This advanced consumer centric app mobilises events, airlines, retail, and hospitality to offer data exchange securely and privately with the individual's full consent. Authorised to handle medical data in US, UK, Iceland and Netherlands with interoperable, verifiable credentials and tech layers required for seamless global travel.

A member of the Good Health Pass Collaborative on Global Standards for data sharing.

See: www.consentry.com

A/NZ enquires: www.idexchange.me

What do you think?

You must be logged in to post a comment.

Comments

IdeaSpies @ 2021.07.31 7:50 AM

Looks like Qantas has plans for a Health Pass. Are you involved?

https://www.zdnet.com/article/qantas-gears-up-to-roll-out-digital-health-pass-ahead-of-international-flights-resuming/

Related Posts

COVID-19

siRNA for Treatment of SARS-CoV-2

RNA interference in animals involves small double-stranded RNA molecules called siRNA. These molecules are valuable tools for studying single gene function in both in vivo and in vitro settings and are also considered a promising class of therapeutics. SiRNA delivery systems fall into two categories: viral and non-viral, including peptides, polymers, and lipids. Studies using synthetic or plasmid-encoded siRNA show its antiviral effects against various viruses, including SARS-CoV. Learn more about siRNA for Treatment of SARS-CoV-2: https://sars-cov-2.creative-biolabs.com/sirna-for-the-treatment-of-sars-cov2.htm

27 September 2023 by Creative Biol... 0 Comments

COVID-19

Vaccine factories in shipping containers

BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing. It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa. Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking. https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/

18 February 2022 by IdeaSpies 0 Comments